Product Information

DAPAGLIFLOZIN 5 MG TABLET is a generic product, priced at $0.1845 per EA under NDC 60505491103. Its NADAC has been published 5 times since May 27, 2026.

Heads up: FDA NDC-directory enrichment for this product is incomplete — manufacturer is not populated for this NDC in the latest weekly file. The NADAC price and history below are still authoritative; the surrounding metadata is limited to what the CMS publication itself carries.

DAPAGLIFLOZIN 5 MG TABLET

$0.1845per EA

NDC

60505491103

Classification

Generic

Last Updated

6/3/2026

Price Statistics

The NADAC for DAPAGLIFLOZIN 5 MG TABLET has been published 5 times since May 27, 2026, and over the history we have for it it has declined 98.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1845 per EA
All-time high$11.4218 (May 27, 2026)
All-time low$0.1845 (Jun 3, 2026)
52-week high$11.4218
52-week low$0.1845
Median price$0.1845
Average price$2.4320
Largest weekly change-98.4% (Jun 3, 2026)
Weeks tracked5
Tracking sinceMay 27, 2026

Price History

1W

0.0%

1M

-98.4%

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-98.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the drug market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of DAPAGLIFLOZIN 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DAPAGLIFLOZIN 5 MG TABLET is $0.1845 per EA (NDC 60505491103), effective Jun 24, 2026.

How has the price of DAPAGLIFLOZIN 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for DAPAGLIFLOZIN 5 MG TABLET has declined 98.4%. It has been tracked across 5 weekly CMS publications since May 27, 2026.

What are the highest and lowest recorded NADAC prices for DAPAGLIFLOZIN 5 MG TABLET?

Since May 27, 2026, the NADAC for DAPAGLIFLOZIN 5 MG TABLET has ranged from a low of $0.1845 (Jun 3, 2026) to a high of $11.4218 (May 27, 2026), with a median of $0.1845 per EA.

Are there cheaper alternatives to DAPAGLIFLOZIN 5 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DAPAGLIFLOZIN 5 MG TABLET, so no direct lower-cost alternative is listed.

Related Drugs

Same classification

No related drugs found.